Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Audit Finding: Revision Control

Regulatory Risks of Obsolete SOPs in Circulation

Posted on By

Regulatory Risks of Obsolete SOPs in Circulation Preventing GMP Failures from Circulating Obsolete SOP Versions Introduction to the Audit Finding 1. What Are Obsolete SOPs? Obsolete SOPs refer to outdated versions of procedures that have been superseded by revised documents but remain accessible or in active use. 2. Why Is This a Problem? Using outdated…

Read More “Regulatory Risks of Obsolete SOPs in Circulation” »

GMP Audit Findings, Revision Control

Audit Risks When SOPs Lack Clear Version Identification

Posted on By

Audit Risks When SOPs Lack Clear Version Identification Ensuring SOP Version Clarity to Prevent Documentation Errors Introduction to the Audit Finding 1. Overview of the Issue When SOPs lack clear indication of the current version, users cannot confirm if they are following the latest approved procedure. This leads to regulatory and quality compliance risks. 2….

Read More “Audit Risks When SOPs Lack Clear Version Identification” »

GMP Audit Findings, Revision Control

GMP Audit Finding: SOPs Revised Without Version History

Posted on By

GMP Audit Finding: SOPs Revised Without Version History Why Missing Version History in SOP Revisions Compromises GMP Control Introduction to the Audit Finding 1. Lack of Change Traceability When SOPs are revised without maintaining version history, it becomes impossible to track what was changed, when, and by whom. 2. Data Integrity Violation Version control ensures…

Read More “GMP Audit Finding: SOPs Revised Without Version History” »

GMP Audit Findings, Revision Control

Uncontrolled Revision of Documents Without QA Approval: A GMP Compliance Risk

Posted on By

Uncontrolled Revision of Documents Without QA Approval: A GMP Compliance Risk GMP Risk of Document Revisions Without QA Oversight and Approval Introduction to the Audit Finding 1. Undocumented Revisions When documents such as SOPs or protocols are revised without formal QA approval, changes go undocumented and unverified. 2. Bypassed Quality Gate QA serves as the…

Read More “Uncontrolled Revision of Documents Without QA Approval: A GMP Compliance Risk” »

GMP Audit Findings, Revision Control

No Revision Log or Audit Trail Maintained: GMP Audit Finding Explained

Posted on By

No Revision Log or Audit Trail Maintained: GMP Audit Finding Explained GMP Risk of Missing Revision Logs and Audit Trails in Document Control Introduction to the Audit Finding 1. Documentation Without History In GMP environments, every controlled document must have a revision log. Its absence leads to non-traceable changes. 2. No Change Visibility Without a…

Read More “No Revision Log or Audit Trail Maintained: GMP Audit Finding Explained” »

GMP Audit Findings, Revision Control

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme